.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

OXYBUTYNIN CHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Oxybutynin Chloride, and what substitute generic drugs are available?

Oxybutynin Chloride is a drug marketed by Mylan, Osmotica Pharm Us, Amneal Pharms, Silarx, Unique Pharm Labs, Usl Pharma, Pharm Assoc, Accord Hlthcare, Mikart, Mylan Pharms Inc, Impax Pharms, Teva Pharms Usa, Wockhardt, Vintage Pharms, Watson Labs, Quantum Pharmics, and Apotex Inc. and is included in nineteen NDAs.

The generic ingredient in OXYBUTYNIN CHLORIDE is oxybutynin chloride. There are sixteen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.

Summary for Tradename: OXYBUTYNIN CHLORIDE

Patents:0
Applicants:17
NDAs:19
Suppliers / Packagers: see list44
Bulk Api Vendors: see list49
Clinical Trials: see list222
Patent Applications: see list1,304
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXYBUTYNIN CHLORIDE at DailyMed

Pharmacology for Tradename: OXYBUTYNIN CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET;ORAL072485-001Apr 19, 1989DISCNNoNo► Subscribe► Subscribe
Quantum Pharmics
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET;ORAL072296-001Dec 8, 1988DISCNNoNo► Subscribe► Subscribe
Mylan
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076702-001Nov 9, 2006RXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076644-001Nov 9, 2006RXNoNo► Subscribe► Subscribe
Teva Pharms Usa
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET;ORAL071655-001Nov 14, 1988RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc